| Innate immunity to adenovirus R Hendrickx, N Stichling, J Koelen, L Kuryk, A Lipiec, UF Greber Human gene therapy 25 (4), 265-284, 2014 | 250 | 2014 |
| Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment M Garofalo, H Saari, P Somersalo, D Crescenti, L Kuryk, L Aksela, ... Journal of controlled release 283, 223-234, 2018 | 121 | 2018 |
| Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice M Garofalo, A Villa, N Rizzi, L Kuryk, B Rinner, V Cerullo, M Yliperttula, ... Journal of Controlled Release 294, 165-175, 2019 | 119 | 2019 |
| Combination of immunogenic oncolytic adenovirus ONCOS-102 with anti-PD-1 pembrolizumab exhibits synergistic antitumor effect in humanized A2058 melanoma huNOG mouse model L Kuryk, ASW Møller, M Jaderberg Oncoimmunology 8 (2), e1532763, 2019 | 105 | 2019 |
| Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma C Capasso, M Hirvinen, M Garofalo, D Romaniuk, L Kuryk, T Sarvela, ... Oncoimmunology 5 (4), e1105429, 2016 | 101 | 2016 |
| From conventional therapies to immunotherapy: melanoma treatment in review L Kuryk, L Bertinato, M Staniszewska, K Pancer, M Wieczorek, S Salmaso, ... Cancers 12 (10), 3057, 2020 | 87 | 2020 |
| Systemic administration and targeted delivery of immunogenic oncolytic adenovirus encapsulated in extracellular vesicles for cancer therapies M Garofalo, A Villa, N Rizzi, L Kuryk, V Mazzaferro, P Ciana Viruses 10 (10), 558, 2018 | 86 | 2018 |
| Heterologous and cross-species tropism of cancer-derived extracellular vesicles M Garofalo, A Villa, D Crescenti, M Marzagalli, L Kuryk, P Limonta, ... Theranostics 9 (19), 5681, 2019 | 68 | 2019 |
| Synergistic anti‐tumor efficacy of immunogenic adenovirus ONCOS‐102 (Ad5/3‐D24‐GM‐CSF) and standard of care chemotherapy in preclinical mesothelioma model L Kuryk, E Haavisto, M Garofalo, C Capasso, M Hirvinen, S Pesonen, ... International Journal of Cancer 139 (8), 1883-1893, 2016 | 55 | 2016 |
| Oncolytic adenovirus loaded with L-carnosine as novel strategy to enhance the antitumor activity M Garofalo, B Iovine, L Kuryk, C Capasso, M Hirvinen, A Vitale, ... Molecular cancer therapeutics 15 (4), 651-660, 2016 | 52 | 2016 |
| Abscopal effect when combining oncolytic adenovirus and checkpoint inhibitor in a humanized NOG mouse model of melanoma L Kuryk, ASW Møller, M Jaderberg Journal of medical virology 91 (9), 1702-1706, 2019 | 43 | 2019 |
| Antitumor‐specific T‐cell responses induced by oncolytic adenovirus ONCOS‐102 (AdV5/3‐D24‐GM‐CSF) in peritoneal mesothelioma mouse model L Kuryk, ASW Møller, M Garofalo, V Cerullo, S Pesonen, R Alemany, ... Journal of Medical Virology 90 (10), 1669-1673, 2018 | 43 | 2018 |
| Toxicological and bio-distribution profile of a GM-CSF-expressing, double-targeted, chimeric oncolytic adenovirus ONCOS-102–Support for clinical studies on advanced cancer … L Kuryk, L Vassilev, T Ranki, A Hemminki, A Karioja-Kallio, O Levälampi, ... PloS one 12 (8), e0182715, 2017 | 41 | 2017 |
| Pilot study of ONCOS-102 and pembrolizumab: remodeling of the tumor microenvironment and clinical outcomes in anti–PD-1–resistant advanced melanoma AN Shoushtari, AJ Olszanski, M Nyakas, TJ Hornyak, JD Wolchok, ... Clinical Cancer Research 29 (1), 100-109, 2023 | 39 | 2023 |
| The multifaceted roles of mast cells in immune homeostasis, infections and cancers A Sobiepanek, Ł Kuryk, M Garofalo, S Kumar, J Baran, P Musolf, ... International journal of molecular sciences 23 (4), 2249, 2022 | 37 | 2022 |
| Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity M Hirvinen, C Capasso, K Guse, M Garofalo, A Vitale, M Ahonen, L Kuryk, ... Molecular Therapy-Oncolytics 3, 2016 | 37 | 2016 |
| Chimeric oncolytic Ad5/3 virus replicates and lyses ovarian cancer cells through desmoglein‐2 cell entry receptor L Kuryk, ASW Møller Journal of medical virology 92 (8), 1309-1315, 2020 | 35 | 2020 |
| A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma C Capasso, A Magarkar, V Cervera-Carrascon, M Fusciello, S Feola, ... Oncoimmunology 6 (9), e1319028, 2017 | 30 | 2017 |
| Environmental surveillance of non-polio enteroviruses in Poland, 2011 M Wieczorek, A Ciąćka, A Witek, Ł Kuryk, A Żuk-Wasek Food and environmental virology 7, 224-231, 2015 | 29 | 2015 |
| Mast cells as a target—A comprehensive review of recent therapeutic approaches J Baran, A Sobiepanek, A Mazurkiewicz-Pisarek, M Rogalska, A Gryciuk, ... Cells 12 (8), 1187, 2023 | 27 | 2023 |